{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "18051910", "DateCompleted": {"Year": "2008", "Month": "11", "Day": "18"}, "DateRevised": {"Year": "2007", "Month": "12", "Day": "06"}, "Article": {"ArticleDate": [], "Language": ["chi"], "ELocationID": [], "Journal": {"ISSN": "1001-5302", "JournalIssue": {"Volume": "32", "Issue": "18", "PubDate": {"Year": "2007", "Month": "Sep"}}, "Title": "Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica", "ISOAbbreviation": "Zhongguo Zhong Yao Za Zhi"}, "ArticleTitle": "[Clinical study of super crush-run Tongxinluo capsule on treatment of stroke].", "Pagination": {"StartPage": "1928", "EndPage": "1931", "MedlinePgn": "1928-31"}, "Abstract": {"AbstractText": ["To evaluate the clinical efficacy and security of super crush-run tong xinluo capsule (SCTXLC) for apoplexy due to energy-deficiency and blood-stasis.", "The randomised controlled double blind non-inferiority trial versus paroxetine, parallel contrast, different Kinds of Techniques and dosage, the clinical trial design was adopted, 144 patients with stroke of convalescent stage were selected by 2 group, which course of diseases was in 2 weekens to 3 months, neurological deficit scores was 8 to 30, grade of acaties of daily living scores was 2 to 5. the treatment group (n = 72) received SCTXLC 0.26 g (a capsule), 4 capsules at a time, three times a day, while that of the control group (n = 72) received common crush-run tong xinluo capsule (CCTXLC) 0.38 g (a capsule), 4 capsules at a time, three times a day, the therapeutic course for both groups was 28 d.", "The synthesis total effective rates of the stroke in treatment group and control group were 91.3% and 87.3% respectively, showing no significant difference. The Lower Bound Upper Bound of Asymptotic 95% Confidence Interval of the total effective rates difference is -4.57%, over the beforehand Lower Bound of 15%, non-inferiority trial versus paroxetine was eligible. The adverse reactions occurred was 1 patient in the treatment group and 2 patients in control group in clinical trial.", "SCTXLC has definite effect for apoplexy due to energy-deficiency and blood-stasis, the efficacy in the treated group was equal to that in the control group, and favourable satety for usage."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Academy of Integrated Traditional and Western Medicine of Hebei province, Shijiazhuang 050035, China."}], "Identifier": [], "LastName": "Wu", "ForeName": "Yi-Ling", "Initials": "YL"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Li", "ForeName": "Tao", "Initials": "T"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Li", "ForeName": "Yan", "Initials": "Y"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Li", "ForeName": "Jia-Kang", "Initials": "JK"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Hu", "ForeName": "Guo-Heng", "Initials": "GH"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Gu", "ForeName": "Chun-Hua", "Initials": "CH"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Gao", "ForeName": "Xue-Dong", "Initials": "XD"}], "PublicationTypeList": ["English Abstract", "Journal Article", "Randomized Controlled Trial", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "China", "MedlineTA": "Zhongguo Zhong Yao Za Zhi", "NlmUniqueID": "8913656", "ISSNLinking": "1001-5302"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Capsules"}, {"RegistryNumber": "0", "NameOfSubstance": "Drug Combinations"}, {"RegistryNumber": "0", "NameOfSubstance": "Drugs, Chinese Herbal"}, {"RegistryNumber": "0", "NameOfSubstance": "Materia Medica"}, {"RegistryNumber": "0", "NameOfSubstance": "Powders"}, {"RegistryNumber": "0", "NameOfSubstance": "tongxinluo"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Activities of Daily Living"}, {"QualifierName": [], "DescriptorName": "Adult"}, {"QualifierName": [], "DescriptorName": "Aged"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": [], "DescriptorName": "Capsules"}, {"QualifierName": [], "DescriptorName": "Double-Blind Method"}, {"QualifierName": [], "DescriptorName": "Drug Administration Schedule"}, {"QualifierName": [], "DescriptorName": "Drug Combinations"}, {"QualifierName": ["administration & dosage", "isolation & purification", "therapeutic use"], "DescriptorName": "Drugs, Chinese Herbal"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["chemistry"], "DescriptorName": "Materia Medica"}, {"QualifierName": [], "DescriptorName": "Middle Aged"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Powders"}, {"QualifierName": ["drug therapy", "physiopathology"], "DescriptorName": "Stroke"}, {"QualifierName": [], "DescriptorName": "Treatment Outcome"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2007", "Month": "12", "Day": "7", "Hour": "9", "Minute": "0"}, {"Year": "2008", "Month": "11", "Day": "19", "Hour": "9", "Minute": "0"}, {"Year": "2007", "Month": "12", "Day": "7", "Hour": "9", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["18051910"]}}], "PubmedBookArticle": []}